March 11th, 2022 – Kyoto, Japan – Hacarus Inc, the leading provider of lightweight and explainable AI, today announced the launch of its ECG platform, along with DS Pharma Animal Health. The device measures and analyzes the heart condition of dogs, to aid in the early detection of cardiac disease, the second leading cause of death for canines.
“With the current COVID-19 pandemic, the bond between people and their pets is becoming even stronger. We are excited to work together with DS pharma and contribute our AI expertise so that our canine friends can live longer and happier lives,” said Kenshin Fujiwara, CEO, and Founder of HACARUS INC.
The innovative ECG platform creates a stress-free and easy-to-use environment for both canine patients and veterinary technicians. Conventional ECG tests typically require dogs to be held down on their side to prevent movement, which is very stressful. However, the new system will obtain readings directly from the pads on the dog’s paw by standing on a 50 by 60 cm sheet for around only 30 seconds (as shown below).
These readings are then analyzed using HACARUS’ AI model that has been trained using diagnosis data from certified veterinary cardiologists. The results are then instantly displayed on the platform’s “Anisapo” website. Requiring no additional veterinary skills to operate, this system is easy for veterinary clinics to adopt.
As the COVID-19 pandemic continues, households in Japan have seen an increase in the number of pets as people have turned to dogs as a means of gaining deeper connections and mental healing.
Moving towards the future, HACARUS and DS Pharma Animal Health have plans to expand the service to a platform that supports a wide range of health-related services, not only for dogs but for other animals as well.
HACARUS INC. provides big insights from small data. Since its founding in 2014, the company has supplied solutions in 100+ AI projects across Medical and Manufacturing fields. Headquartered in Kyoto, Japan, and backed by Osaka Gas and Miyako Capital (Kyoto University), among others, HACARUS technology continues to enable humans to make better, faster, and more reliable decisions based on data-driven insight. HACARUS’ proprietary AI engine was built using Sparse Modeling, a method that understands data like a human would – by its unique key features and is far more resource, time, and energy-efficient when compared to Deep Learning. To learn more, visit https://hacarus.com.
About DS Pharma Animal Health Co., Ltd.
DS Pharma Animal Health is an R&D company established in July 2010 as a separate company from the business division of Dainippon Sumitomo Pharma Co., Ltd. Based on the experience and results gained through more than 70 years in the animal medicine business the company manufactures and markets pharmaceutical products for animals. In addition to medicines and functional foods, the company is expanding its business domain to the entire veterinary healthcare cycle – examinations, diagnoses, medicines, and aftercare – and promoting transformation into a company that provides smart solutions. Please visit https://animal.ds-pharma.co.jp/.